Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Valneva SE

Deal Watch: AstraZeneca Out-Licenses Pneumonia Candidate, Obtains STING Inhibitors

Pharma moves Phase III-ready antibody to prevent pneumonia to Aridis, licenses preclinical STING inhibitors from F-star. Sanofi teams with SRI on AI-directed discovery, Biogen licenses BTK inhibitor from InnoCare.

Deal Watch Business Strategies

Deal Watch: Pfizer Invests In Spero, Parexel Trades Hands

EQT and Goldman Sachs to pay $8.5bn in Parexel’s second private equity buyout in four years.

Deal Watch Business Strategies

Valneva Seeks Covid Vaccine Approval On AstraZeneca Head-To-Head Data Alone

The partnership between Valneva and the UK government could produce the first COVID vaccine approval based on immunogenicity data.

Commercial Companies

UK Trial Could Help Pick Best Covid Vaccine Boosters

Results will be important in fight against new variants, for second-generation vaccines and AstraZeneca’s controversy-hit jab.

Commercial Companies
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Biotechnology
    • Drug Discovery Tools
    • Synthesis Technologies, Production Processes
    • Transgenics
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • BliNK Biomedical SAS
    • Crucell Sweden AB
    • Iomai Corporation
    • Intercell USA, Inc.
    • Intercell AG, Vivalis
UsernamePublicRestriction

Register